NCT05881707View on ClinicalTrials.gov

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

September 2, 2023

Study Completion Date

September 27, 2023

Conditions
Hypertension
Interventions
DRUG

CKD-828, D064, D702

QD, PO

Trial Locations (1)

Unknown

Jeonbuk National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY